Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study of TTC-352 in Patients With Metastatic Breast Cancer Progressing on Endocrine Therapy

NCT03201913 is registered in ClinicalTrials.gov with TTC Oncology, LLC as lead sponsor.

NCT NCT03201913
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03201913 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study of TTC-352 in Patients With Metastatic Breast Cancer Progressing on Endocrine Therapy
Lead sponsor
TTC Oncology, LLC
Phase
Phase 1
Overall status
Completed
Start date
December 11, 2017
Completion date
April 30, 2020
Enrollment
15 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic er+ breast cancer